{"id":"https://openalex.org/W95316889","doi":null,"title":"[Antidepressants consumption in the global population in France].","display_name":"[Antidepressants consumption in the global population in France].","publication_year":2002,"publication_date":"2002-09-01","ids":{"openalex":"https://openalex.org/W95316889","mag":"95316889","pmid":"https://pubmed.ncbi.nlm.nih.gov/12386542"},"language":"fr","primary_location":{"id":"pmid:12386542","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12386542","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"L'Encephale","raw_type":"English Abstract"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110099911","display_name":"Jean\u2010Pierre Oli\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124863","display_name":"Centre Hospitalier Sainte-Anne","ror":"https://ror.org/02kxjxy06","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210124863"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J P Oli\u00e9","raw_affiliation_strings":["Service Hospitalo-Universitaire, CH Sainte-Anne, 1, rue Cabanis, 75014 Paris-Universit\u00e9 Paris V, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service Hospitalo-Universitaire, CH Sainte-Anne, 1, rue Cabanis, 75014 Paris-Universit\u00e9 Paris V, France","institution_ids":["https://openalex.org/I4210124863","https://openalex.org/I4387156284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028308881","display_name":"F Elomari","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F Elomari","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083395938","display_name":"C. Spadone","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Spadone","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5109143609","display_name":"Jean\u2010Pierre L\u00e9pine","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J P L\u00e9pine","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5471,"has_fulltext":false,"cited_by_count":61,"citation_normalized_percentile":{"value":0.65576837,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"28","issue":"5 Pt 1","first_page":"411","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10272","display_name":"Mental Health Treatment and Access","score":0.888700008392334,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10272","display_name":"Mental Health Treatment and Access","score":0.888700008392334,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.10100000351667404,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13118","display_name":"Psychological Treatments and Disorders","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antidepressant-use","display_name":"antidepressant use","score":0.8519999980926514},{"id":"https://openalex.org/keywords/antidepressant-prescribing","display_name":"antidepressant prescribing","score":0.6639999747276306},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9900000095367432},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.8700000047683716},{"id":"https://openalex.org/keywords/paroxetine","display_name":"paroxetine","score":0.996999979019165},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.3970000147819519},{"id":"https://openalex.org/keywords/anxiety-disorders","display_name":"anxiety disorders","score":0.8840000033378601},{"id":"https://openalex.org/keywords/somatic-comorbidity","display_name":"somatic comorbidity","score":0.890999972820282},{"id":"https://openalex.org/keywords/prescription-duration","display_name":"prescription duration","score":0.4659999907016754},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.6460000276565552},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5210000276565552},{"id":"https://openalex.org/keywords/drug-abuse","display_name":"drug abuse","score":0.35100001096725464},{"id":"https://openalex.org/keywords/drug-addiction","display_name":"drug addiction","score":0.6129999756813049}],"concepts":[{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.8083247542381287},{"id":"https://openalex.org/C2778963718","wikidata":"https://www.wikidata.org/wiki/Q12757","display_name":"CIDI","level":4,"score":0.7907909154891968},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6769371628761292},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.6050064563751221},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.5879373550415039},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5340976119041443},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.5254727602005005},{"id":"https://openalex.org/C2777669559","wikidata":"https://www.wikidata.org/wiki/Q407617","display_name":"Sertraline","level":4,"score":0.5012521743774414},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.4897637367248535},{"id":"https://openalex.org/C30772137","wikidata":"https://www.wikidata.org/wiki/Q5164762","display_name":"Consumption (sociology)","level":2,"score":0.43099403381347656},{"id":"https://openalex.org/C2778834376","wikidata":"https://www.wikidata.org/wiki/Q7696504","display_name":"Telephone interview","level":2,"score":0.4157496690750122},{"id":"https://openalex.org/C149923435","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demography","level":1,"score":0.3248465061187744},{"id":"https://openalex.org/C2776317618","wikidata":"https://www.wikidata.org/wiki/Q544006","display_name":"Anxiety disorder","level":3,"score":0.26046884059906006},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.20773988962173462},{"id":"https://openalex.org/C36289849","wikidata":"https://www.wikidata.org/wiki/Q34749","display_name":"Social science","level":1,"score":0.0},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005602","descriptor_name":"France","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011159","descriptor_name":"Population Surveillance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:12386542","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12386542","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"L'Encephale","raw_type":"English Abstract"},{"id":"mag:95316889","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12386542","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2412885318","https://openalex.org/W1583784105","https://openalex.org/W2463362935","https://openalex.org/W2499668087","https://openalex.org/W2990204903","https://openalex.org/W7134846112","https://openalex.org/W134885520","https://openalex.org/W2307252204","https://openalex.org/W2106445044","https://openalex.org/W2913698857"],"abstract_inverted_index":{"The":[0,98,138,164,177,185,283,306,358,391,513,664,775],"consumption":[1,19],"of":[2,20,32,42,52,77,105,113,149,160,172,206,249,255,286,309,338,344,370,382,401,412,425,443,459,471,482,490,525,531,536,540,555,576,587,631,637,655,683,696,715,722,738,751],"antidepressant":[3,53,194,250,273,288,314,330,339,375,387,431,468,494],"seems":[4],"to":[5,39,64,101,146,167,223,293,303,328,709,735],"be":[6,710,719],"in":[7,11,27,47,55,62,66,74,125,142,203,278,336,364,410,415,421,454,612,660,667,672,680,713,753,757],"France":[8,758],"higher":[9],"than":[10,511,732,766],"comparable":[12],"countries,":[13,26],"as":[14,16,226,566,786],"well":[15],"the":[17,30,40,50,56,71,75,87,103,118,121,126,161,173,204,207,236,246,279,287,297,310,342,371,383,396,402,426,444,457,460,465,491,493,520,542,546,577,588,596,603,616,621,638,643,653,661,673,677,686,699,723,739,749,754,770,780,787,791,795],"overall":[18,57,72],"healthcare":[21],"and":[22,120,131,158,217,322,379,417,479,508,579,690,794],"medications.":[23],"In":[24,45,464,538],"Western":[25],"recent":[28],"years,":[29,266],"use":[31,41,54,205,651],"antidepressants":[33,345,420,507,591,705,752,765],"has":[34],"regularly":[35],"increased,":[36],"mainly":[37],"due":[38],"serotoninergic":[43],"antidepressants.":[44,176,703,774],"France,":[46],"a":[48,78,144,147,169,221,242,352,406,438,485,499,529,563,574,609,629,632,729],"week,":[49],"prevalence":[51],"population":[58,73,174,756],"increased":[59],"from":[60,235],"1.7%":[61],"1992":[63],"3%":[65],"1995.":[67],"This":[68,646,745],"survey":[69,746,776],"addressed":[70],"form":[76],"representative":[79,159],"sample":[80],"focusing":[81],"on":[82,245,590,652,688,701,725],"subjects":[83,152,186,311,372,384,556,589,687,700,724],"who":[84,187],"indicated,":[85],"at":[86,315,346,376,388],"time":[88,247,316,347,377,389],"they":[89,93,190],"were":[90,94,191,195,270,350,367,404,428,446,473,666,727],"consulted,":[91],"that":[92,189,365,432,545,717,748],"taking":[95,175,192,271,312,351,373,385,405,429,448,728],"an":[96,193,200,272,313,374,386,430,435,476,581],"antidepressant.":[97,440],"study":[99],"aimed":[100],"determine":[102],"circumstances":[104],"prescription:":[106],"prescriber":[107],"file,":[108],"reason":[109,132,515,547],"for":[110,133,395,516,548,599,620,642,676,685,693,698],"prescription,":[111],"type":[112],"medication":[114],"prescribed,":[115],"match":[116],"between":[117,782],"prescription":[119,129,517],"product":[122,622,644],"indications":[123,619,641],"stated":[124,188,544,671],"marketing":[127,617,639,662,674],"authorization,":[128],"duration":[130],"discontinuing":[134],"treatment.":[135],"Methodology":[136],"-":[137,212,253,744],"first":[139],"stage":[140],"consisted":[141],"forwarding":[143],"letter":[145],"panel":[148],"44":[150,260],"000":[151,257,261],"aged":[153,263],"15":[154,265],"years":[155],"or":[156,274,533,559,573,650,733],"more":[157,509,764],"French":[162],"population.":[163],"aim":[165],"was":[166,180,239,290,318,334,433,496,522,550],"achieve":[168],"cross-sectional":[170],"description":[171],"response":[178],"rate":[179],"82%":[181],"(36":[182],"036":[183],"subjects).":[184],"re-contacted":[196],"by":[197,199,475,484,498,519,528,790],"telephone":[198],"interviewer":[201],"trained":[202],"Composite":[208],"International":[209],"Diagnostic":[210],"Interview":[211],"lifetime":[213],"(CIDI),":[214],"exploring":[215],"depression":[216,523],"anxiety":[218,532,583],"diseases":[219],"with":[220,301,456,615,628,669],"view":[222],"potential":[224],"diagnosis":[225,611,630],"per":[227,567],"DSM":[228],"criteria.":[229],"Longitudinal":[230],"follow-up":[231],"over":[232,264],"8":[233],"months":[234],"initial":[237],"screening":[238],"evaluated":[240],"using":[241],"monthly":[243],"questionnaire":[244],"course":[248],"consumption.":[251,331],"Results":[252],"Out":[254],"20":[256],"households,":[258],"comprising":[259],"people":[262,269,604],"1":[267,294,480],"333":[268],"had":[275,560,608],"taken":[276],"one":[277,736],"previous":[280],"4":[281],"weeks.":[282],"sex":[284,299],"ratio":[285,300],"consumers":[289,343,403,427],"3":[291],"women":[292],"man,":[295],"amplifying":[296],"known":[298],"respect":[302],"depressive":[304],"disorders.":[305],"mean":[307],"age":[308],"t":[317],"51":[319],"years.":[320],"Lifestyle":[321],"socioprofessional":[323],"category":[324],"did":[325,592],"not":[326,551,593,658],"seem":[327],"influence":[329],"Somatic":[332],"comorbidity":[333],"present":[335],"60%":[337,489],"consumers.":[340],"Among":[341,602],"t,":[348],"45%":[349],"selective":[353],"serotonin":[354],"reuptake":[355],"inhibitor":[356],"(SSRI).":[357],"two":[359],"products":[360],"most":[361,771],"widely":[362,772],"prescribed":[363,497,773],"class":[366],"fluoxetine":[368],"(30%":[369],"t)":[378],"paroxetine":[380,689],"(10%":[381],"t).":[390],"other":[392,418],"SSRIs":[393,510,768],"accounted":[394],"remaining":[397],"5%.":[398],"Thirty-nine":[399],"percent":[400,554,586],"tricyclic":[407,419,439,506,702],"antidepressant:":[408],"clomipramine":[409,726],"16%":[411],"cases,":[413,541],"amitriptyline":[414],"14%,":[416],"9%.":[422],"Lastly,":[423],"20%":[424],"neither":[434],"SSRI":[436],"nor":[437],"Only":[441],"4%":[442],"patients":[445],"concomitantly":[447],"2":[449],"antidepressants:":[450],"single-agent":[451],"therapy":[452],"is":[453,759],"line":[455,668],"recommendations":[458],"various":[461],"expert":[462],"groups.":[463],"survey,":[466],"9":[467],"prescriptions":[469],"out":[470,481,779],"10":[472,483],"written":[474],"open-care":[477],"practitioner,":[478],"hospital":[486],"physician.":[487],"For":[488],"subjects,":[492],"treatment":[495,549],"general":[500],"practitioner.":[501],"General":[502],"practitioners":[503],"prescribe":[504],"less":[505,731],"specialists.":[512],"main":[514],"reported":[518],"patient":[521],"(57%":[524],"cases);":[526],"followed":[527],"state":[530],"stress":[534],"(15%":[535],"cases).":[537],"10%":[539],"consumer":[543],"psychological.":[552],"Sixty-two":[553],"presented":[557,561,627],"with,":[558,562],"mood":[564,571],"disorder":[565],"M-CIDI":[568,597],"(major":[569],"depression,":[570],"disorder,":[572],"combination":[575],"two)":[578],"14%":[580],"isolated":[582],"disorder.":[584],"Twenty-five":[585],"fulfill":[594],"all":[595],"criteria":[598],"any":[600],"diagnosis.":[601],"receiving":[605],"antidepressants,":[606],"54%":[607],"CIDI":[610],"strict":[613],"compliance":[614],"authorization":[618,640,675],"considered.":[623],"One":[624],"quarter":[625],"(25%)":[626],"characterized":[633],"psychiatric":[634],"disease,":[635],"outside":[636],"taken.":[645],"finding":[647],"reflects":[648],"misuse":[649],"basis":[654],"published":[656],"data":[657],"incorporated":[659],"authorization.":[663],"dosages":[665],"those":[670],"disease":[678],"considered":[679],"almost":[681],"99%":[682],"cases":[684,697],"fluoxetine,":[691],"but":[692],"only":[694],"22%":[695],"Tricyclic":[704],"would":[706,718],"therefore":[707],"appear":[708],"frequently":[711],"inappropriately":[712],"terms":[714],"proportions":[716],"ineffective:":[720],"half":[721],"dose":[730],"equal":[734],"third":[737],"minimum":[740],"recommended":[741],"dose.":[742],"Conclusion":[743],"shows":[747],"point-prevalence":[750],"global":[755],"about":[760],"3.5%.":[761],"Women":[762],"consume":[763],"men.":[767],"are":[769],"findings":[777],"point":[778],"discrepancies":[781],"official":[783],"indications,":[784],"such":[785],"ones":[788],"issued":[789],"regulatory":[792],"authorities,":[793],"physicians'":[796],"prescribing":[797],"practices.":[798]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}